As of 2024-12-11, the Relative Valuation of Spectrum Pharmaceuticals Inc (SPPI) is (7.35) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.03 USD, the upside of Spectrum Pharmaceuticals Inc based on Relative Valuation is -813.7%.
The range of the Relative Valuation is (6.87) - (6.41) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.7x - 31.7x | 26.7x |
| Forward P/E multiples | 19.2x - 20.3x | 19.8x |
| Fair Price | (6.87) - (6.41) | (7.35) |
| Upside | -767.5% - -722.6% | -813.7% |
| Date | P/E |